Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization

Erythropoietin (EPO) is a well-known hormone that is clinically used for the treatment of anemia. Very recently, an increasing body of evidence showed that EPO could still regulate bioactivities of macrophages. However, the details about the immunomodulatory effect of EPO on macrophages are not full...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Dis
Autors principals: Wang, Shuo, Zhang, Chao, Li, Jiawei, Niyazi, Sidikejiang, Zheng, Long, Xu, Ming, Rong, Ruiming, Yang, Cheng, Zhu, Tongyu
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477572/
https://ncbi.nlm.nih.gov/pubmed/28383559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.104
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars